When was Moximed founded?

Moximed was founded in 2006 and raised its 1st funding round 2 years after it was founded.

Where is Moximed located?

Moximed is headquartered in Hayward, United States. It is registered at Fremont, California.

How many employees does Moximed have?

As of Apr 30, 2026, the latest employee count at Moximed is 81.

Is Moximed a funded company?

Moximed is a funded company, having raised a total of $262M across 8 funding rounds to date. The company's 1st funding round was a $***** Series B round, raised on Jun 2008.

When was the latest funding round of Moximed?

Moximed's latest funding was a $***** Series D round on Aug 07, 2024, with participation from 10 investors.

Where does Moximed rank among its competitors?

Moximed ranks 1st amongst 16 active competitors, of which 8 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was CoreTissue BioEngineering, which secured $3.91M in Nov, 2025.

Who are the top competitors of Moximed?

Moximed's top competitors include Hyalex, Allay Therapeutics and Jointmedica. Among them, CoreTissue BioEngineering secured the most recent funding round in November, 2025.

Moximed - 2026 Company Profile, Team, Funding & Competitors

Company Details

Developer of an implant for pre-arthroplasty osteoarthritis patients. The lead product, the KineSpring Knee Implant System, is designed for patients with knee osteoarthritis. It's a partial load absorber that reduces knee joint load by up to 13 kg.

Website: moximed.com
Registered Address: Fremont, California

Key Metrics

Founded Year

2006

Location

Hayward, United States

Stage

Series D

Total Funding

$262M in 8 rounds

Latest Funding Round

Series D, Aug 07, 2024, $*****

Investors

Future Fund & 14 more

Ranked

1^st among 16 active competitors

Employee Count

81 as on Apr 30, 2026

Similar Companies

Hyalex & 17 more

View Moximed's full profile

Moximed is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
MOXIMED INC. CIN: 205769994 , United States, Active	Dec 26, 999	-	45 (As on Dec 31, 2024)	-

Moximed has raised a total funding of $262M over 8 rounds. Its first funding round was on Jun 2008. Its latest funding round was a Series D round on Aug 07, 2024 for $*****. 10 investors participated in its latest round. Moximed has 15 institutional investors.

Here is the list of recent funding rounds of Moximed:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Aug 07, 2024	3984040	Series D	3840184	7825157	3587587	6241903
Aug 16, 2022	6561888	Series C	7867111	4074105	9932015	Advent Life Sciences & 5 more
Aug 16, 2022	3955627	Conventional Debt	1045592	8547414	5049513	Runway Growth Capital

Access funding benchmarks and valuations. Sign up today!

View details of Moximed's funding rounds and investors

The founders of Moximed is Josh Makower.

Here are the details of Moximed's key team members:

Josh Makower: Founder & Chairman of Moximed and founder of 2 other companies, Willow and Stanford University. They are also an angel investor in 1 startup and serve on the board of 1 company.

Moximed's Board of Directors

Moximed's board has 20 active members. Ryan Drant, Joshua Makower, Dan Murray, Christopher Shen, Michael Wasserman, Shahzad Malik, Robert W. Croce, Robert K. Anderson, Arthur Franken, James Leech, Kevin K. Sidow, David van Meter, David Amerson, Henry A. Plain, Matt McAviney, Anton Clifford, John Nehra, Henry A. Plain, Jr., Christopher Gleason and Robert More are independent board members.

Here is the list of Moximed's board of directors:

Name	Type	Representing	Status	Duration
Ryan Drant	Independent board member	-	Current	16y 6m
wqpvvwi	Independent board member	-	Current	6y 3m
evohswp	Independent board member	-	Current	9y 2m
anpvfzu	Independent board member	-	Current	3y 7m
qpefwiu	Independent board member	-	Current	4y 1m
ilovwij	Independent board member	-	Current	5y 6m
jzvejwa	Independent board member	-	Current	8y 9m
bwmorpf	Independent board member	-	Current	2y 4m
gowd{xq	Independent board member	-	Current	3y 6m
sbzdsyo	Independent board member	-	Current	3y 7m
pgcewnb	Independent board member	-	Current	6y 7m
{mi{hbt	Independent board member	-	Current	9y 1m
lbxdr{r	Independent board member	-	Current	8y 4m
ieclkrb	Independent board member	-	Current	1y 1m
vnxcuox	Independent board member	-	Current	2y 5m
giruxci	Independent board member	-	Current	5y 6m
ztd{lom	Independent board member	-	Current	6y 8m
dsmpock	Independent board member	-	Current	8y 6m
{{enh{s	Independent board member	-	Current	8y 5m
ajcbtzk	Independent board member	-	Current	7y 3m

View details of Moximed's Founder profiles and Board Members

Moximed's employee count trend

Moximed has 81 employees as of Apr 26. Here is Moximed's employee count trend over the years:

Uncover Moximed's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Moximed include Hyalex, Allay Therapeutics and Jointmedica. Here is the list of Top 10 competitors of Moximed, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Moximed 2006, Hayward (United States), Series D	Developer of an implant for pre-arthroplasty osteoarthritis patients	$262M	Advent Life Sciences, Frazier Healthcare Partners ... & 13 others	51/100
2nd	Hyalex 2016, Lexington (United States), Series A	Developer of a synthetic cartilage platform to restore damaged joint surfaces	$46.4M	Strategic Healthcare Investment Partners, Canaan ... & 5 others	61/100
3rd	Allay Therapeutics 2017, Menlo Park (United States), Series D	Developer of drugs for post-surgical pain management	$159M	Arboretum Ventures, Lightstone Ventures & 15 others	58/100
4th	Jointmedica 2008, Worcester (United Kingdom), Seed	Provider of smart devices for knee replacement	-	ExacTech, SETsquared	47/100
5th	CoreTissue BioEngineering 2016, Yokohama (Japan), Series A	Developer of implantable medical devices derived from living tissues	$3.91M	Waseda University, MMA Investment & 5 others	46/100
6th	Biotech Healthcare 1999, Lucerne (Switzerland), Unfunded	Manufacturer of ophthalmic, orthopedic, and aesthetic medical products. The company develops and produces intraocular lenses, viscosupplements, and dermal fillers. Its ophthalmology products support cataract and refractive surgery, while its orthopedics offerings address joint pain and mobility. The aesthetics product line focuses on skin rejuvenation. The company's manufacturing facilities utilize advanced technologies to ensure product quality and efficacy.	-	-	42/100
7th	Sparta Biomedical 2017, Research Triangle Park (United States), Seed	Developing cartilage-like implants to treat osteoarthritis and restore joint function	$5M	Duke University, Nanosha	39/100
8th	Optimotion Implants 2016, Orlando (United States), Seed	Developer of knee replacement implants and surgical devices	$2.25M	-	29/100
9th	Hippos Exoskeleton 2024, San Francisco (United States), Seed	Developer of wearable airbag technology designed for knee joint protection	$642K	Possible Ventures, Silicon Roundabout Ventures ... & 1 others	25/100
10th	Engage Surgical 2017, Orlando (United States), Acqui-Hired	Developer of smart devices for a partial knee replacement system	-	-	21/100